Last edition
News about "Biocon Ltd"
Biocon & Mylan Win Patent Litigation Asserted by Sanofi for Insulin Glargine Device
Biocon Ltd.announced today that it has won a U.S. court ruling that invalidated a Sanofi patent on the Insulin Glargine device , removing a key legal hurdle to commercializing Semglee® (Insulin Glargine) co-developed with Mylan, in the U.S.
Biocon Ltd | 15/03/2020 | By Darshana | 243
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members